Does community outreach actually work?
It can, dramatically. In one Alzheimer's study, a community outreach event recruited 69 subjects, while an intervention aimed at primary care physicians recruited none (PubMed). The lesson is not that physicians do not matter, but that how you reach people matters as much as who you reach.
Why is there room to grow?
Most people are never asked. Only 10% of people who never participated in a trial were ever invited (CISCRP), while 87% say they are somewhat or very willing to participate (CISCRP via Citeline).
Which partners work best?
- Patient advocacy groups for the specific condition.
- Senior centers for age related conditions.
- Faith communities with health ministries.
- Community health centers and local clinics.
- Pharmacies that see patients on relevant medications.
How do you run outreach a site can sustain?
- Pick one or two partners per therapeutic area, not ten.
- Lead with education about the condition, not a study pitch.
- Use IRB approved materials for anything study specific; FDA treats recruitment ads and flyers as materials IRBs review (FDA).
- Return regularly; trust builds over repeated visits.
- Capture interest with consent to contact, then follow up within days.
How does outreach connect to physicians?
Patients who hear about research at a community event usually want to ask their own doctor: 95% say it is important their doctor is aware of studies (CISCRP). If that doctor already knows your site and study, the conversation moves forward instead of stalling. Outreach and physician referral work best together.
Get your study in front of the right local physicians
TrialNotice builds a physician referral pipeline around one active study. We identify relevant local physicians within driving distance of your site, send study aligned direct mail, follow up by email and LinkedIn, track engagement with recipient level QR codes, and route warm responses into your site team's workflow.
Talk to TrialNoticeSources
- "Comparison of recruitment efforts targeted at primary care physicians versus the community at large for participation in Alzheimer disease clinical trials," PubMed
- CISCRP, 2017 Perceptions and Insights Study: Decision Making Process
- CISCRP, Highlights from the 2017 Perceptions and Insights Study
- FDA, "Recruiting Study Subjects" guidance for IRBs and clinical investigators
- Citeline, Patient Recruitment Pulse (Jan 2026) on the CISCRP 2025 Perceptions and Insights Study